Assesses fractional lung cancer model effects of chemotherapy, hypoxia, and immunotherapy, suggesting implications for treatment strategies.
The study strives to formulate and examine a fractional nonlinear dynamic model of lung cancer that integrates the impacts of chemotherapy, hypoxia, and immunotherapy. The presence and uniqueness of the fractional lung cancer model have been shown. The Hyers–Ulam stability of the lung cancer model is examined as well. A lung cancer model has been assessed quantitatively using the Atangana–Toufik methodology. A computer simulation demonstrates that chemotherapy, hypoxia, and immunotherapy significantly reduce the dissemination of lung cancer to other regions.
No takes yet. Share an insight, caveat, or question.
Tabassum et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: